Drugs / Reverse Genetic (RG) reassortant A/H9N2 influenza vaccine
Reverse Genetic (RG) reassortant A/H9N2 influenza vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01320696 | Mar → Jun 2011 | influenza | Alachua Government Services, Inc. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Reverse Genetic (RG) reassortant A/H9N2 influenza vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01320696 ↗ |
| Modality | Vaccine | “influenza vaccine” NCT01320696 ↗ |
| Route | Intramuscular | “Two intramuscular vaccinations” NCT01320696 ↗ |